Silvia Scali

869 citations
20 papers · 702 indexed · h-index 14
Topics
Antimicrobial Peptides and Activities (8 papers)Peptidase Inhibition and Analysis (5 papers)Biochemical and Structural Characterization (4 papers)
Partner nations
ItalySouth AfricaIsrael

In The Last Decade

Silvia Scali

20 papers receiving 691 citations

Peers

Silvia Scali
Comparison fields: 5 of 92
  • Molecular Biology 344
  • Microbiology 261
  • Genetics 138
  • Oncology 131
  • Cancer Research 107
Replace Tianyuan Zhang with:
Tianyuan Zhang China
Jung Su Ryu United States
Shuhong Qi China
Giulia Riolo Italy
Bibiana Franzen Matte Brazil
Tarmo Mölder Estonia
Stina Lindberg Sweden
Supriya Patil India
Pia Unterberger Germany
Silvia Scali relative to Tianyuan Zhang China Tianyuan Zhang's profile →
Citations per field
00.5×3.8×
Tianyuan Zhang · 1×
Citations per year

Countries citing papers authored by Silvia Scali

Since Specialization
Citations

This map shows the geographic impact of Silvia Scali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Scali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Scali more than expected).

Fields of papers citing papers by Silvia Scali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Scali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Scali. The network helps show where Silvia Scali may publish in the future.

Co-authorship network of co-authors of Silvia Scali

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Scali. A scholar is included among the top collaborators of Silvia Scali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Scali. Silvia Scali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 3
3 16
4 12
5 40
6 10
7 24
8 50
9 73
10 38
11 12
12 32
13 9
14 26
15 67
16 27
17 51
18 158
19 20
20
The Effect of Haptic Feedback and Stereo Graphics in a 3D Target Acquisition Task
31

About Silvia Scali

Silvia Scali is a scholar working on Microbiology, Molecular Medicine and Molecular Biology, having authored 20 papers that have together received 702 indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (8 papers), Peptidase Inhibition and Analysis (5 papers) and Biochemical and Structural Characterization (4 papers). The work is most often cited by research in Microbiology (261 citations), Molecular Medicine (55 citations) and Cancer Research (107 citations). Silvia Scali has collaborated with scholars based in Italy, South Africa and Israel. Frequent co-authors include Alessandro Pini, Luisa Bracci, Chiara Falciani, Jlenia Brunetti, Luisa Lozzi, Stefano Bindi, Barbara Lelli, Gian María Rossolini, Lorenzo Depau and Simona Pollini. Their work appears in journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026